Skip to main content
Journal cover image

Transforming growth factor-beta1 antisense treatment of rat vein grafts reduces the accumulation of collagen and increases the accumulation of h-caldesmon.

Publication ,  Journal Article
Wolff, RA; Malinowski, RL; Heaton, NS; Hullett, DA; Hoch, JR
Published in: J Vasc Surg
May 2006

BACKGROUND: The main cause of occlusion and vein graft failure after peripheral and coronary arterial reconstruction is intimal hyperplasia. Transforming growth factor beta-1 (TGF-beta1) is a pleiotropic cytokine known to have powerful effects on cell growth, apoptosis, cell differentiation, and extracellular matrix synthesis. METHODS: To investigate the role of TGF-beta1 in intimal hyperplasia, we used adenovirus to deliver to superficial epigastric vein messenger RNA (mRNA) antisense to TGF-beta1 (Ad-AST) or the sequence encoding the bioactive form of TGF-beta1 (Ad-BAT). Infection with "empty" virus was used as a control (Ad-CMVpLpA). The treated vein was then used for an interposition graft into rat femoral artery. Grafts were harvested at 1, 2, 4, and 12 weeks and formalin-fixed for histologic studies or placed in liquid nitrogen for mRNA studies. RESULTS: Ad-AST treatment resulted in an overall reduction of TGF-beta1 expression (P = .001), and Ad-BAT treatment resulted in an overall increase in TGF-beta1 expression (P = .007). Histologic analysis showed Ad-AST caused reduced collagen build up in the neointima at 12 weeks (P = .0001). Immunohistochemical staining for h-caldesmon at 12 weeks indicated Ad-AST increased smooth muscle cells throughout the vessel wall compared with Ad-CMVpLpA (P = .0024) or Ad-BAT (P = .04). Ad-AST also resulted in reduced CD68-positive cells in the media/adventitia (P = .005 vs Ad-CMVpLpA, P = .01 vs Ad-BAT). To further understand how Ad-AST was influencing the build up of collagen, we performed quantitative polymerase chain reaction on complimentary DNA (cDNA) from homogenates of the vein grafts. Tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) was increased at 1 week by Ad-BAT (P = .048 vs Ad-CMVpLpA) and decreased by Ad-AST at all time points (P

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Vasc Surg

DOI

ISSN

0741-5214

Publication Date

May 2006

Volume

43

Issue

5

Start / End Page

1028 / 1036

Location

United States

Related Subject Headings

  • Veins
  • Tunica Intima
  • Transforming Growth Factor beta1
  • Transforming Growth Factor beta
  • Tissue Inhibitor of Metalloproteinase-1
  • Rats
  • RNA, Messenger
  • RNA, Antisense
  • Graft Occlusion, Vascular
  • Gene Expression Regulation
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Wolff, R. A., Malinowski, R. L., Heaton, N. S., Hullett, D. A., & Hoch, J. R. (2006). Transforming growth factor-beta1 antisense treatment of rat vein grafts reduces the accumulation of collagen and increases the accumulation of h-caldesmon. J Vasc Surg, 43(5), 1028–1036. https://doi.org/10.1016/j.jvs.2006.01.016
Wolff, Randal A., Rita L. Malinowski, Nicholas S. Heaton, Debra A. Hullett, and John R. Hoch. “Transforming growth factor-beta1 antisense treatment of rat vein grafts reduces the accumulation of collagen and increases the accumulation of h-caldesmon.J Vasc Surg 43, no. 5 (May 2006): 1028–36. https://doi.org/10.1016/j.jvs.2006.01.016.
Wolff, Randal A., et al. “Transforming growth factor-beta1 antisense treatment of rat vein grafts reduces the accumulation of collagen and increases the accumulation of h-caldesmon.J Vasc Surg, vol. 43, no. 5, May 2006, pp. 1028–36. Pubmed, doi:10.1016/j.jvs.2006.01.016.
Journal cover image

Published In

J Vasc Surg

DOI

ISSN

0741-5214

Publication Date

May 2006

Volume

43

Issue

5

Start / End Page

1028 / 1036

Location

United States

Related Subject Headings

  • Veins
  • Tunica Intima
  • Transforming Growth Factor beta1
  • Transforming Growth Factor beta
  • Tissue Inhibitor of Metalloproteinase-1
  • Rats
  • RNA, Messenger
  • RNA, Antisense
  • Graft Occlusion, Vascular
  • Gene Expression Regulation